Convalescent plasma treatment for SARS-CoV-2 infection: analysis of the first 436 donors in England, 22 April to 12 May 2020

Serological reactivity was analysed in plasma from 436 individuals with a history of disease compatible with COVID-19, including 256 who had been laboratory-confirmed with SARS-CoV-2 infection. Over 99% of laboratory-confirmed cases developed a measurable antibody response (254/256) and 88% harboure...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Euro Surveill
Autors principals: Harvala, Heli, Mehew, Jennifer, Robb, Matthew L, Ijaz, Samreen, Dicks, Steven, Patel, Monika, Watkins, Nicholas, Simmonds, Peter, Brooks, Tim, Johnson, Rachel, Gopal, Robin, Roberts, David J, Zambon, Maria, Thomas, Stephen, MacLennan, Sheila, Estcourt, Lise, Brailsford, Su, Baklan, Hatice, Tettmar, Kate, Kellington, Jeremy, Sell, Joanne, Miflin, Gail
Format: Artigo
Idioma:Inglês
Publicat: European Centre for Disease Prevention and Control (ECDC) 2020
Matèries:
Rapid Communication
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7376844/
https://ncbi.nlm.nih.gov/pubmed/32700670
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2807/1560-7917.ES.2020.25.28.2001260
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars